Kapitalizacja Rynkowa Zmiana Data
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Arrowhead Research USD 10.84B 664M 2026-08
Astellas Pharma JPY 4.1T 160.64B 2026-08
BioCryst Pharmaceuticals USD 1.9B 643M 2026-08
BioMarin Pharmaceutical USD 11.71B 651M 2026-08
Cspc Pharmaceutical CNY 99.86B 3.93B 2026-08
Deva Holding AS TRY 17.54B 7.76B 2023-09
Divis Laboratories Ltd INR 2.21T 464.84B 2026-08
Exelixis USD 15.27B 1.73B 2026-08
Halozyme Therapeutics USD 10.91B 1.63B 2026-08
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Kangmei Pharma CNY 24.48B 3.45B 2026-03
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Malin Corporation EUR 133.52M 29.05M 2026-08
Medical Developments International AUD 37.11M 25.41M 2026-08
Nektar Therapeutics USD 12.98B 10.86B 2026-08
Neuren Pharmaceuticals AUD 2.44B 80.57M 2026-08
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Novartis USD 240.59B 67.17B 2026-06
OPKO Health USD 2.73B 1.76B 2026-03
Organigram Holdings CAD 252.47M 59.69M 2026-03
Ovoca Bio EUR 5.1M 3.93M 2026-08
Pfizer USD 153.17B 14.73B 2026-08
Pharma Mar EUR 1.39B 78.26M 2026-08
Qiagen NV USD 8.47B 396.81M 2026-08
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sarepta Therapeutics USD 1.5B 402M 2026-08
Sartorius EUR 15.63B 1.38B 2026-06
Ultragenyx Pharmaceutical USD 2.12B 1.16B 2026-08
Vertex Pharmaceuticals USD 137.33B 11.26B 2026-08
Zealand Pharma A/S 33.35B 12.51B 2026-08